The FDA is forcing Pfizer and Moderna to expand warning labels about the risks of two forms of heart damage, myocarditis and ...

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

The updated warnings highlight a rare risk of heart inflammation in teen boys and young men, CBS News reported. The warning ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...

FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...

Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the ...

Moderna, Inc. (NASDAQ:MRNA) made a name for itself by quickly developing an effective coronavirus vaccine when the world needed it the most. However, the stock has largely struggled since the pandemic ...

Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.

The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...

Moderna ...

[２１日ロイター] - 米バイオ医薬品会社モデルナ(MRNA.O), opens new ...

Moderna Inc.（以下、「モデルナ」）の日本法人モデルナ・ジャパン株式会社（東京都港区、以下、「モデルナ・ジャパン」）は5月19日付けで、60歳以上の成人を対象としたRSウイルスによる感染症の予防を目的とした「エムレスビア(R)筋注シリンジ」の日本における製造販売承認を取得したのでお知らせします。